Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.
D000208:Acute Disease; D000818:Animals; D000917:Antibody Formation; D001323:Autoantibodies / Q000302:isolation & purification; D001327:Autoimmune Diseases; D001402:B-Lymphocytes / Q000276:immunology; D002462:Cell Membrane / Q000276:immunology; D002908:Chronic Disease; D003601:Cytotoxicity Tests, Immunologic; D000939:Epitopes; D006680:HLA Antigens / Q000302:isolation & purification; D006505:Hepatitis / Q000209:etiology / Q000276:immunology*; D006509:Hepatitis B / Q000209:etiology / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D006510:Hepatitis B Antibodies; D006511:Hepatitis B Antigens; D006801:Humans; D007111:Immunity, Cellular; D007136:Immunoglobulins / Q000008:administration & dosage; D007167:Immunotherapy; D008074:Lipoproteins / Q000276:immunology; D008099:Liver / Q000276:immunology / Q000473:pathology; D011817:Rabbits; D013601:T-Lymphocytes / Q000276:immunology*
D001323:Autoantibodies; D000939:Epitopes; D006680:HLA Antigens; D006510:Hepatitis B Antibodies; D006511:Hepatitis B Antigens; D007136:Immunoglobulins; D008074:Lipoproteins